Genetic Study of Early Onset Parkinson's Disease in Cyprus
- PMID: 36499697
- PMCID: PMC9739936
- DOI: 10.3390/ijms232315369
Genetic Study of Early Onset Parkinson's Disease in Cyprus
Abstract
Parkinson's Disease (PD) is a multifactorial neurodegenerative disease characterized by motor and non-motor symptoms. The etiology of PD remains unclear. However, several studies have demonstrated the interplay of genetic, epigenetic, and environmental factors in PD. Early-onset PD (EOPD) is a subgroup of PD diagnosed between the ages of 21 and 50. Population genetic studies have demonstrated great genetic variability amongst EOPD patients. Hence, this study aimed to obtain a genetic landscape of EOPD in the Cypriot population. Greek-Cypriot EOPD patients (n = 48) were screened for variants in the six most common EOPD-associated genes (PINK1, PRKN, FBXO7, SNCA, PLA2G6, and DJ-1). This included DNA sequencing and Multiplex ligation-dependent probe amplification (MLPA). One previously described frameshift variant in PINK1 (NM_032409.3:c.889del) was detected in five patients (10.4%)-the largest number to be detected to date. Copy number variations in the PRKN gene were identified in one homozygous and 3 compound heterozygous patients (8.3%). To date, the pathogenic variants identified in this study have explained the PD phenotype for 18.8% of the EOPD cases. The results of this study may contribute to the genetic screening of EOPD in Cyprus.
Keywords: Greek-Cypriot Parkinson’s patients; early onset Parkinson’s disease (EOPD); genetic investigation.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
References
-
- Dorsey E.R., Elbaz A., Nichols E., Abd-Allah F., Abdelalim A., Adsuar J.C., Ansha M.G., Brayne C., Choi J.Y.J., Collado-Mateo D., et al. Global, regional, and national burden of Parkinson’s disease, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:939–953. doi: 10.1016/S1474-4422(18)30295-3. - DOI - PMC - PubMed
-
- Maserejian A.D.N., Vinikoor-Imler L. Estimation of the 2020 Global Population of Parkinson’s Disease (PD) [(accessed on 14 September 2021)];Mov. Disord. 2020 35 Available online: https://www.mdsabstracts.org/abstract/estimation-of-the-2020-global-popu...
-
- Milanowski Ł.M., Lindemann J.A., Hoffman-Zacharska D., Soto-Beasley A.I., Barcikowska M., Boczarska-Jedynak M., Deutschlander A., Kłodowska G., Dulski J., Fedoryshyn L., et al. Frequency of Mutations in PRKN, PINK1, and DJ1 in Patients with Early-Onset Parkinson Disease from Neighboring Countries in Central Europe. Park. Relat. Disord. 2021;86:48. doi: 10.1016/j.parkreldis.2021.03.026. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
